• TG Therapeutics average return on tangible equity for 2023 was -165.64, a 9.93% decline from 2022.
• TG Therapeutics average return on tangible equity for 2022 was -150.68, a 62.34% increase from 2021.
• TG Therapeutics average return on tangible equity for 2021 was -92.82, a 91.5% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.